uric acid has been researched along with Nocturia in 1 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Nocturia: Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or bladder inflammation (CYSTITIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Lower hemoglobin level, higher serum uric acid level, self-reported history of nocturia, and family history of kidney disease are independent risk factors for ESRD." | 3.75 | Risk factors for end-stage renal disease: 25-year follow-up. ( Darbinian, J; Go, AS; Hsu, CY; Iribarren, C; McCulloch, CE, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, CY | 1 |
| Iribarren, C | 1 |
| McCulloch, CE | 1 |
| Darbinian, J | 1 |
| Go, AS | 1 |
1 other study available for uric acid and Nocturia
| Article | Year |
|---|---|
Risk factors for end-stage renal disease: 25-year follow-up.
Topics: Adult; Aged; Aged, 80 and over; Black or African American; Confidence Intervals; Creatinine; Female; | 2009 |